-
公开(公告)号：US20240335632A1
公开(公告)日：2024-10-10
申请号：US18409651
申请日：2024-01-10
发明人： Bruce Gordon Holyoake , Dexter Chi Lun Cheung , Anil Patel , Seyed Ahmad Reza Nouraei , Milanjot Singh Assi , Thomas Heinrich Barnes , Alicia Jerram Hunter Evans , Craig Karl White , Matthew John Payton , Laith Adeeb Hermez , German Klink , Samantha Dale Oldfield , Taylor James Edwards , Aidan Robert Burgess
IPC分类号： A61M16/06 , A61M16/00 , A61M16/01 , A61M16/08 , A61M16/10 , A61M16/12 , A61M16/16 , A61M16/20 , A61M39/26
CPC分类号： A61M16/0666 , A61M16/0051 , A61M16/0066 , A61M16/0078 , A61M16/01 , A61M16/024 , A61M16/06 , A61M16/0616 , A61M16/0672 , A61M16/0858 , A61M16/0875 , A61M16/16 , A61M16/201 , A61M16/202 , A61M16/209 , A61M39/26 , A61M2016/0027 , A61M2016/0033 , A61M16/0683 , A61M16/0688 , A61M16/0816 , A61M2016/1025 , A61M2016/103 , A61M2016/1035 , A61M16/105 , A61M16/109 , A61M16/1095 , A61M16/12 , A61M16/161 , A61M16/208 , A61M2202/0208 , A61M2202/0241 , A61M2205/0216 , A61M2205/13 , A61M2205/14 , A61M2205/3303 , A61M2205/3306 , A61M2205/3317 , A61M2205/332 , A61M2205/3334 , A61M2205/3365 , A61M2205/3368 , A61M2205/3375 , A61M2205/3569 , A61M2205/3592 , A61M2205/505 , A61M2205/507 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2230/04 , A61M2230/06 , A61M2230/10 , A61M2230/201 , A61M2230/202 , A61M2230/205 , A61M2230/60 , A61M2230/63
摘要： The invention relates to a respiratory system comprising a first patient interface for delivery of a first flow of gases to a patient, a second patient interface for delivery of a second flow of gases to the patient, and a device and/or sensing arrangement that is configure to facilitate a switching of the system between a first respiratory mode where the device allowing delivery of the first flow of gases to an outlet of the first patient interface when the second patient interface is absent from the patient, and a second respiratory mode where the device reducing or stopping delivery of the first flow of gases to the outlet of the first patient interface when the second patient interface is located together with the first patient interface upon the patient.
-
公开(公告)号：US20190134318A1
公开(公告)日：2019-05-09
申请号：US16114372
申请日：2018-08-28
申请人： INDOSE INC
发明人： Daniel Freeman , Ari Freeman , Jacqueline Freeman
CPC分类号： A61M11/00 , A24F47/008 , A61M11/042 , A61M15/0013 , A61M15/002 , A61M15/008 , A61M15/06 , A61M16/0866 , A61M2016/1035 , A61M2205/3306 , A61M2205/3313 , A61M2205/3334 , A61M2205/3653 , A61M2205/50 , A61M2205/58 , A61M2205/6063 , A61M2206/20
摘要： An inhalation device for inhaling a vaporized substance that includes metering capabilities to inform a user when a particular amount of substance has been consumed. The device includes an inlet having an opening, an outlet, a processor, an atomizer configured to vaporize an unvaporized substance into a vaporized substance. The device further includes a channel positioned between the atomizer and the outlet, wherein the vaporized substance flows downstream from the atomizer to the outlet via the channel, a light signal device, wherein the light signal device emits light, and a light sensor, wherein the light sensor senses the light from the light signal device. In addition, the light signal device and the sensor are positioned in the channel such that the vaporized substance can flow past the sensor and the light signal device, the opening is configured to allow entry of air into the device that flows to the atomizer, the inlet is configured such that the air flows at a substantially constant rate, and the processor, using the substantially constant rate and the data from the light sensor, is configured to meter an amount of vapor consumed by a user.
-
公开(公告)号：US09981097B2
公开(公告)日：2018-05-29
申请号：US15277253
申请日：2016-09-28
发明人： Craig R. Tolmie , Jeff Milsap , Jaron M. Acker
IPC分类号： A61M16/00 , G01N33/00 , A61M16/20 , A61M16/12 , A61M16/10 , A61M16/08 , G01N27/416 , A61M16/16
CPC分类号： A61M16/0051 , A61M16/0003 , A61M16/024 , A61M16/085 , A61M16/1005 , A61M16/12 , A61M16/16 , A61M16/201 , A61M2016/102 , A61M2016/1035 , A61M2202/0275 , A61M2205/18 , A61M2205/27 , A61M2205/33 , A61M2205/502 , A61M2205/52 , A61M2205/581 , A61M2205/583 , A61M2205/70 , A61M2205/702 , G01N27/4163 , G01N33/0006 , G01N33/0008 , G01N33/0037 , Y02A50/245 , A61M2202/0007
摘要： Described are systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors atypical use in systems for delivering therapeutic nitric oxide gas to a patient. The long term sensitivity drift of catalytic type electrochemical gas sensors may be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can be used to reduce the amount of times the sensor goes offline.
-
公开(公告)号：US09956364B2
公开(公告)日：2018-05-01
申请号：US15341142
申请日：2016-11-02
发明人： Craig R. Tolmie , Jeff Milsap , Jaron M. Acker
IPC分类号： A61M16/00 , G01N33/00 , G01N27/416 , A61M16/08 , A61M16/12 , A61M16/20 , A61M16/16 , A61M16/10
CPC分类号： A61M16/0051 , A61M16/0003 , A61M16/024 , A61M16/085 , A61M16/1005 , A61M16/12 , A61M16/16 , A61M16/201 , A61M2016/102 , A61M2016/1035 , A61M2202/0275 , A61M2205/18 , A61M2205/27 , A61M2205/33 , A61M2205/502 , A61M2205/52 , A61M2205/581 , A61M2205/583 , A61M2205/70 , A61M2205/702 , G01N27/4163 , G01N33/0006 , G01N33/0008 , G01N33/0037 , Y02A50/245 , A61M2202/0007
摘要： Described are systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors atypical use in systems for delivering therapeutic nitric oxide gas to a patient. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can be used reduce the amount of times the sensor goes offline. Systems and methods described may factor in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.
-
公开(公告)号：US09919118B2
公开(公告)日：2018-03-20
申请号：US15341584
申请日：2016-11-02
发明人： Craig R. Tolmie , Jeff Milsap , Jaron M. Acker
IPC分类号： A61M16/00 , G01N33/00 , A61M16/20 , A61M16/12 , A61M16/10 , A61M16/08 , G01N27/416 , A61M16/16
CPC分类号： A61M16/0051 , A61M16/0003 , A61M16/024 , A61M16/085 , A61M16/1005 , A61M16/12 , A61M16/16 , A61M16/201 , A61M2016/102 , A61M2016/1035 , A61M2202/0275 , A61M2205/18 , A61M2205/27 , A61M2205/33 , A61M2205/502 , A61M2205/52 , A61M2205/581 , A61M2205/583 , A61M2205/70 , A61M2205/702 , G01N27/4163 , G01N33/0006 , G01N33/0008 , G01N33/0037 , Y02A50/245 , A61M2202/0007
摘要： Systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can reduce the amount of times the sensor goes offline. Systems and methods may factor in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.
-
6.发明授权公开(公告)号：US09885653B1
公开(公告)日：2018-02-06
申请号：US15667019
申请日：2017-08-02
发明人： Ralf Buchtal , Livio Fornasiero , Robert Jahns , Heike Vöhringer
CPC分类号： G01N21/3504 , A61M16/0072 , A61M16/01 , A61M16/024 , A61M16/0833 , A61M16/085 , A61M16/0891 , A61M16/104 , A61M16/12 , A61M16/22 , A61M2016/1035 , A61M2202/0241 , A61M2202/0283 , A61M2205/3313 , A61M2205/502 , A61M2230/432 , A61M2230/437 , G01J3/26 , G01J3/42 , G01J3/45 , G01N2021/3137 , G01N2201/12 , A61M2202/0007
摘要： A device analyzes an anesthesia ventilation gas with an infrared radiation source and includes a gas cuvette, a Fabry-Perot interferometer with a band pass filter function, adjustable with respect to a central transmission wavelength as a function of a control signal, a detector providing a measured signal and a computing and control unit providing the control signal and detecting the measured signal. The computing and control unit is configured to actuate the Fabry-Perot interferometer in a first operating mode by the control signal such that the central transmission wavelength scans a predefined wavelength range, to detect a presence in the ventilation gas sample potential types of anesthetic gases based on the measured signal. In a second operating mode, the control unit controls the central transmission wavelength within a subrange of the predefined wavelength range and determines a plurality of concentration values at consecutive times for detected types of anesthetic gases.
-
7.发明申请公开(公告)号：US20180000859A1
公开(公告)日：2018-01-04
申请号：US15702091
申请日：2017-09-12
申请人： PROTERRIS, INC.
发明人： Jeffrey D. Wager , Joseph Wager , Alex Stenzler , David Pinsky , Augustine Choi
CPC分类号： A61K33/00 , A61M16/0051 , A61M16/026 , A61M16/10 , A61M16/12 , A61M2016/1035 , A61M2202/0208 , A61M2202/0233 , G01N33/721 , G01N2333/805 , G01N2800/52 , A61M2202/0007
摘要： The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack.
-
公开(公告)号：US09827394B2
公开(公告)日：2017-11-28
申请号：US14344126
申请日：2012-09-18
发明人： Judith Hall , Alison Paul , Antony Wilkes
CPC分类号： A61M16/18 , A61D7/04 , A61K9/0073 , A61K9/1075 , A61M15/0006 , A61M16/10 , A61M16/104 , A61M16/14 , A61M2016/1035 , A61M2202/048 , A61M2205/123 , A61M2209/06
摘要： The invention concerns a cartridge for an inhalation device for delivering anaesthetic to a human or animal wherein anaesthetic in the cartridge is dispersed in an anaesthetic control release medium; an inhalation device for use with the cartridge and a formulation including at least one selected anaesthetic and anaesthetic control release medium.
-
9.发明授权公开(公告)号：US09789133B2
公开(公告)日：2017-10-17
申请号：US14687740
申请日：2015-04-15
申请人： Proterris Inc.
发明人： Jeffrey D. Wager , Joseph Wager , Alex Stenzler , David Pinsky , Augustine Choi
CPC分类号： A61K33/00 , A61M16/0051 , A61M16/026 , A61M16/10 , A61M16/12 , A61M2016/1035 , A61M2202/0208 , A61M2202/0233 , G01N33/721 , G01N2333/805 , G01N2800/52 , A61M2202/0007
摘要： The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack.
-
公开(公告)号：US09770569B2
公开(公告)日：2017-09-26
申请号：US11806292
申请日：2007-05-31
申请人： Ralf Heesch
发明人： Ralf Heesch
CPC分类号： A61M16/104 , A61M16/0051 , A61M16/0063 , A61M16/0072 , A61M16/01 , A61M16/024 , A61M16/10 , A61M16/12 , A61M16/18 , A61M16/22 , A61M2016/0039 , A61M2016/0042 , A61M2016/102 , A61M2016/1025 , A61M2016/103 , A61M2016/1035
摘要： A method for measuring the anesthetic agent consumption in a ventilation system has a breathing circuit which contains a gas mixer (1) and an anesthetic agent metering device (2). The anesthetic agent quantity, which is consumed over a pregiven time interval in the ventilation system, is determined from the sum of the determined anesthetic gas volume flows in the ventilation system which are integrated over the pregiven time interval.
-
-
-
-
-
-
-
-
-
搜索结果
346 条记录 (耗时 0.039 秒)
